Association between SGLT2 (sodium-glucose cotransporter-2) inhibitors and bladder cancer in individuals with type 2 diabetes; a systematic review and meta-analysis

• Main Authors: Mobin Mohammadtabar (Author), Alireza Fazeli (Author), Najmeh Parsai (Author), Zahra Aboulfathiyarmohammadyar (Author), Erfan Shafiei (Author), Mohamad Khaledi (Author), Elahe Zaremoghadam (Author), Ali Rahnama Sisakht (Author), Saeid Mohammadi (Author), Hossein Mardanparvar (Author)
• Format: Book
• Published: Society of Diabetic Nephropathy Prevention, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are the most recent pharmaceutical group for type 2 diabetes (T2D) treatment. Evidence indicates contradictory relationships between sodium-glucose cotransporter-2 inhibitors and bladder cancer (BC). Hence, this study aims to investigat...